These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17165179)

  • 21. Breast cancer prevention in countries with diverse resources.
    McTiernan A; Porter P; Potter JD
    Cancer; 2008 Oct; 113(8 Suppl):2325-30. PubMed ID: 18837024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yes, you can help yourself beat cancer. Strategies include tried and true home remedies like cutting back on fat in your diet and increasing exercise.
    Health News; 2005 Sep; 11(9):7-8. PubMed ID: 16208808
    [No Abstract]   [Full Text] [Related]  

  • 23. Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors.
    Harputluoglu H; Dizdar O; Karaahmet F; Altundag K
    Breast Cancer Res Treat; 2008 Aug; 110(3):541. PubMed ID: 17851754
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of women at high risk for breast cancer.
    Arun B
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S71-7. PubMed ID: 19795579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New breast cancer treatment.
    Environ Health Perspect; 1995 Mar; 103(3):223. PubMed ID: 7768219
    [No Abstract]   [Full Text] [Related]  

  • 26. Patient advocacy profile: Susan G. Komen Breast Cancer Foundation.
    Maza J
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):129-30. PubMed ID: 16163177
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.
    Toi M; Yamashiro H; Tsuji W
    Breast Cancer; 2009; 16(3):207-18. PubMed ID: 19259765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing of weight gain and breast cancer risk.
    Stoll BA
    Cancer; 1996 Jan; 77(1):210. PubMed ID: 8630933
    [No Abstract]   [Full Text] [Related]  

  • 29. Longterm followup assessment of a HER2/neu peptide (E75) vaccine for prevention of recurrence in high-risk prostate cancer patients.
    Gates JD; Carmichael MG; Benavides LC; Holmes JP; Hueman MT; Woll MM; Ioannides CG; Robson CH; McLeod DG; Ponniah S; Peoples GE
    J Am Coll Surg; 2009 Feb; 208(2):193-201. PubMed ID: 19228530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight cycling in a very low-calorie diet programme has no effect on weight loss velocity, blood pressure and serum lipid profile.
    Li Z; Hong K; Wong E; Maxwell M; Heber D
    Diabetes Obes Metab; 2007 May; 9(3):379-85. PubMed ID: 17391166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiotherapy for high-risk patients after radical prostatectomy for prostate cancer: immediate postoperative or salvage?].
    Pasquier D; Kouto H; Ballereau C
    Prog Urol; 2009 Jul; 19(7):447-56. PubMed ID: 19559374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Paradoxical interactions between pregnancy and breast cancer].
    Mathelin C; Youssef C; Brettes JP; Rio MC
    Gynecol Obstet Fertil; 2007 May; 35(5):449-56. PubMed ID: 17434331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research.
    Neilson HK; Friedenreich CM; Brockton NT; Millikan RC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):11-27. PubMed ID: 19124476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema.
    Shaw C; Mortimer P; Judd PA
    Cancer; 2007 Oct; 110(8):1868-74. PubMed ID: 17823909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of local failure following prostate brachytherapy.
    Stone NN; Stock RG; White I; Unger P
    J Urol; 2007 May; 177(5):1759-63; duscussion 1763-4. PubMed ID: 17437808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.
    Nanda A; Chen MH; Renshaw AA; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1419-23. PubMed ID: 19131185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comment on dose escalation and biochemical failure in prostate cancer: in regard to Kuban et al. (Int J Radiat Oncol Biol Phys 2008;70:67-74).
    Schulz RJ; Kagan AR
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1288; author reply 1288-9. PubMed ID: 18572089
    [No Abstract]   [Full Text] [Related]  

  • 38. Commentary on dose escalation and biochemical failure in prostate cancer: in regard to Eade et al. (Int. J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
    Schulz RJ; Kagan AR
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207038
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostate-specific antigen control with low-dose adjuvant radiotherapy for high-risk prostate cancer.
    Macdonald OK; Lee RJ; Snow G; Lee CM; Tward JD; Middleton AW; Middleton GW; Sause WT
    Urology; 2007 Feb; 69(2):295-9. PubMed ID: 17320667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cancer prevention].
    Scheurlen M
    MMW Fortschr Med; 2008 Jul; 150(28-31):34. PubMed ID: 19006889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.